- Home
- ENTA vs IMPP Comparison
ENTA vs IMPP Comparison
Compare ENTA & IMPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTA
- IMPP
- Stock Information
- Founded
- ENTA 1995
- IMPP 1981
- Country
- ENTA United States
- IMPP Greece
- Employees
- ENTA N/A
- IMPP N/A
- Industry
- ENTA Biotechnology: Pharmaceutical Preparations
- IMPP Marine Transportation
- Sector
- ENTA Health Care
- IMPP Consumer Discretionary
- Exchange
- ENTA Nasdaq
- IMPP Nasdaq
- Market Cap
- ENTA 109.0M
- IMPP 100.2M
- IPO Year
- ENTA 2013
- IMPP N/A
- Fundamental
- Price
- ENTA $5.09
- IMPP $2.98
- Analyst Decision
- ENTA Buy
- IMPP
- Analyst Count
- ENTA 4
- IMPP 0
- Target Price
- ENTA $17.25
- IMPP N/A
- AVG Volume (30 Days)
- ENTA 503.4K
- IMPP 327.0K
- Earning Date
- ENTA 02-18-2025
- IMPP 02-11-2025
- Dividend Yield
- ENTA N/A
- IMPP N/A
- EPS Growth
- ENTA N/A
- IMPP N/A
- EPS
- ENTA N/A
- IMPP 1.51
- Revenue
- ENTA $67,635,000.00
- IMPP $151,150,129.00
- Revenue This Year
- ENTA $8.11
- IMPP N/A
- Revenue Next Year
- ENTA N/A
- IMPP $36.01
- P/E Ratio
- ENTA N/A
- IMPP $2.01
- Revenue Growth
- ENTA N/A
- IMPP N/A
- 52 Week Low
- ENTA $4.71
- IMPP $2.72
- 52 Week High
- ENTA $17.80
- IMPP $4.59
- Technical
- Relative Strength Index (RSI)
- ENTA 38.07
- IMPP 45.33
- Support Level
- ENTA $4.94
- IMPP $2.72
- Resistance Level
- ENTA $5.31
- IMPP $2.98
- Average True Range (ATR)
- ENTA 0.32
- IMPP 0.14
- MACD
- ENTA 0.11
- IMPP -0.01
- Stochastic Oscillator
- ENTA 39.05
- IMPP 25.33
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.
About IMPP Imperial Petroleum Inc.
Imperial Petroleum Inc is a provider of international seaborne transportation services to oil producers, refineries, and commodities traders. It owns and operates a fleet of six medium-range product tankers that carry refined petroleum products such as gasoline, diesel, fuel oil and jet fuel, as well as edible oils and chemicals.